These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 744197)

  • 1. Kellersberger Memorial Lecture 1978. Leprosy control--present position and future prospects.
    Browne SG
    Ethiop Med J; 1978 Oct; 16(4):169-78. PubMed ID: 744197
    [No Abstract]   [Full Text] [Related]  

  • 2. The Kellersberger memorial lecture, 1985. The role of BCG in the control of leprosy.
    Fine PE
    Ethiop Med J; 1985 Oct; 23(4):179-91. PubMed ID: 4054106
    [No Abstract]   [Full Text] [Related]  

  • 3. The Kellersberger memorial lecture, 1984. Chemotherapy of leprosy--a tool for leprosy control.
    Levy L
    Ethiop Med J; 1985 Jan; 23(1):31-42. PubMed ID: 3965285
    [No Abstract]   [Full Text] [Related]  

  • 4. Kellersberger memorial lecture, 1988. Technology for leprosy control--progress and prospects.
    Noordeen SK
    Ethiop Med J; 1989 Jul; 27(3):161-80. PubMed ID: 2666127
    [No Abstract]   [Full Text] [Related]  

  • 5. [Leprosy in Guadeloupe].
    Floch HA
    Bull Soc Pathol Exot Filiales; 1972; 65(1):35-46. PubMed ID: 4677872
    [No Abstract]   [Full Text] [Related]  

  • 6. The 20th Kellersberger Memorial Lecture, 1994. Leprosy and tuberculosis combined programmes: an uneasy partnership?
    Saunderson P
    Ethiop Med J; 1994 Oct; 32(4):269-80. PubMed ID: 7835357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO expert committee on leprosy.
    World Health Organ Tech Rep Ser; 1970; 459():3-31. PubMed ID: 4993944
    [No Abstract]   [Full Text] [Related]  

  • 8. Srategy of leprosy control.
    WHO Chron; 1978 May; 32(5):193-9. PubMed ID: 664625
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of secondary dapsone resistance in Gudiyattam Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 1. Preliminary report.
    Balraj V; Jesudasan K; Chacko CJ; Christian M; Taylor PM; Fritschi EP; Job CK
    Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):397-401. PubMed ID: 7193654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Kellersberger Memorial Lecture, 1981. The general situation of leprosy in the world.
    Sansarricq H
    Ethiop Med J; 1982 Apr; 20(2):89-106. PubMed ID: 7084218
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemoprophylaxis and BCG vaccination against leprosy.
    Guinto RS
    Int J Lepr Other Mycobact Dis; 1966; 34(3):313-6. PubMed ID: 5950353
    [No Abstract]   [Full Text] [Related]  

  • 12. The evaluation of present antileprosy compounds.
    Browne SG
    Adv Pharmacol Chemother; 1969; 7():211-51. PubMed ID: 4910168
    [No Abstract]   [Full Text] [Related]  

  • 13. Leprosy--a complementary contribution.
    Trop Doct; 1973 Jul; 3(3):97-8. PubMed ID: 4736659
    [No Abstract]   [Full Text] [Related]  

  • 14. Leprosy in children and its impact on community health.
    Hazra SK; Ghosh S
    Indian J Dermatol; 1981 Jan; 26(1):1-7. PubMed ID: 7347315
    [No Abstract]   [Full Text] [Related]  

  • 15. [British research on leprosy].
    Lambert R
    Med Trop (Madr); 1968; 44(3):271-5. PubMed ID: 5737630
    [No Abstract]   [Full Text] [Related]  

  • 16. On simultaneous BCG vaccination and DDS chemoprophylaxis.
    Long ER
    Int J Lepr Other Mycobact Dis; 1969; 37(4):412-5. PubMed ID: 5394261
    [No Abstract]   [Full Text] [Related]  

  • 17. United States-Japan Leprosy and Tuberculosis Conference.
    Yoshie Y
    Int J Lepr Other Mycobact Dis; 1966; 34(3):311-3. PubMed ID: 5950352
    [No Abstract]   [Full Text] [Related]  

  • 18. [Survey on the prevalence rate of dapsone-resistant leprosy in the Yangzhou district].
    Li WZ; Ye GY; Wang HY; Tao MB; Ma B; Zhang YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Feb; 6(1):59-61. PubMed ID: 6238701
    [No Abstract]   [Full Text] [Related]  

  • 19. WHO experience in the therapeutic control of leprosy.
    Bechelli LM
    Int J Lepr Other Mycobact Dis; 1971; 39(4):885-9. PubMed ID: 5170476
    [No Abstract]   [Full Text] [Related]  

  • 20. Leprosy at a turning point?
    Harboe M
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.